by Nicole Kuchinsky | Dec 1, 2015
November was a big month for science in Canada. Our new prime minister, Justin Trudeau, sent a clear message that science will be a priority for his administration by naming Dr. Kirsty Duncan Minister of Science, and Navdeep Bains Minister of Innovation, Science and...
by Mark Curtis | Nov 24, 2015
Welcome to your Cell Therapy Deal Review for the month of October. Lion Biotechnologies and Kite Pharma both made deals with the National Institutes of Health (NIH) that significantly expanded their respective pipelines. Kite also announced a research collaboration...
by David Kent | Nov 16, 2015
The United Kingdom has begun its foray into using cells derived from human embryonic stem cells (ESCs) in clinical settings. I have to admit I was surprised that following coverage on the BBC and in The Guardian, there was virtually no anti-ESC protesting to be found,...
by Holly Wobma | Nov 10, 2015
The last two decades have seen a number of fascinating innovations in biomaterial scaffolds development. This comes from the growing realization that 2D culture of cells can only do so much in terms of mimicking physiological niches of the body. To encourage...
by Hamideh Emrani | Nov 9, 2015
Continuing with the theme of interesting biomaterials-related talks at the recent Till & McCulloch Meetings in Toronto, Canada, was the one delivered by Professor Molly Shoichet from the University of Toronto. Her group focuses on designing polymer scaffolds to...
Comments